Attached files

file filename
EX-14 - NOVAVAX INCv176992_ex14.htm
EX-10.14 - NOVAVAX INCv176992_ex10-14.htm
EX-10.45 - NOVAVAX INCv176992_ex10-45.htm
EX-10.15 - NOVAVAX INCv176992_ex10-15.htm
EX-10.11 - NOVAVAX INCv176992_ex10-11.htm
EX-10.19 - NOVAVAX INCv176992_ex10-19.htm
EX-10.13 - NOVAVAX INCv176992_ex10-13.htm
EX-10.37 - NOVAVAX INCv176992_ex10-37.htm
EX-23.1 - NOVAVAX INCv176992_ex23-1.htm
EX-31.2 - NOVAVAX INCv176992_ex31-2.htm
EX-31.1 - NOVAVAX INCv176992_ex31-1.htm
EX-32.1 - NOVAVAX INCv176992_ex32-1.htm
10-K - NOVAVAX INCv176992_10k.htm
Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO 18 UNITED STATES C. §1350
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Annual Report of Novavax, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederick W. Driscoll, Vice President, Chief Financial Officer and Treasurer, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
 
1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the dates and periods covered by this Report.
 

By:
/s/ Frederick W. Driscoll
Vice President, Chief Financial Officer and Treasurer

Date: March 16, 2010